nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS3—Doxorubicin—sarcoma	0.281	0.413	CbGbCtD
L-Arginine—NOS2—Doxorubicin—sarcoma	0.281	0.413	CbGbCtD
L-Arginine—SLC22A5—Dactinomycin—sarcoma	0.117	0.173	CbGbCtD
L-Arginine—NOS2—Effects of Nitric Oxide—MB—sarcoma	0.0174	0.132	CbGpPWpGaD
L-Arginine—NOS3—Effects of Nitric Oxide—MB—sarcoma	0.0135	0.103	CbGpPWpGaD
L-Arginine—NOS3—pulmonary artery—sarcoma	0.00998	0.0787	CbGeAlD
L-Arginine—NOS3—umbilical vein—sarcoma	0.0066	0.052	CbGeAlD
L-Arginine—ASL—mammary gland—sarcoma	0.00643	0.0507	CbGeAlD
L-Arginine—NOS2—Effects of Nitric Oxide—HBA1—sarcoma	0.00627	0.0476	CbGpPWpGaD
L-Arginine—NOS3—hindlimb—sarcoma	0.00604	0.0476	CbGeAlD
L-Arginine—NOS3—appendage—sarcoma	0.00518	0.0408	CbGeAlD
L-Arginine—SLC22A4—larynx—sarcoma	0.00497	0.0392	CbGeAlD
L-Arginine—AZIN2—myometrium—sarcoma	0.00491	0.0387	CbGeAlD
L-Arginine—NOS3—Effects of Nitric Oxide—HBA1—sarcoma	0.00487	0.037	CbGpPWpGaD
L-Arginine—NOS2—tendon—sarcoma	0.00368	0.029	CbGeAlD
L-Arginine—ARG2—mammary gland—sarcoma	0.00361	0.0284	CbGeAlD
L-Arginine—NOS3—endothelium—sarcoma	0.00313	0.0247	CbGeAlD
L-Arginine—NOS3—Angiogenesis—TEK—sarcoma	0.00299	0.0227	CbGpPWpGaD
L-Arginine—ASL—uterus—sarcoma	0.00296	0.0233	CbGeAlD
L-Arginine—Skin necrosis—Etoposide—sarcoma	0.0029	0.0465	CcSEcCtD
L-Arginine—AZIN2—tendon—sarcoma	0.00279	0.022	CbGeAlD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—VEGFC—sarcoma	0.00274	0.0208	CbGpPWpGaD
L-Arginine—SLC7A3—testis—sarcoma	0.00259	0.0204	CbGeAlD
L-Arginine—ASS1—mammary gland—sarcoma	0.00253	0.0199	CbGeAlD
L-Arginine—NOS3—mammary gland—sarcoma	0.00252	0.0199	CbGeAlD
L-Arginine—SLC7A4—testis—sarcoma	0.00241	0.019	CbGeAlD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.00238	0.0181	CbGpPWpGaD
L-Arginine—AZIN2—testis—sarcoma	0.00231	0.0182	CbGeAlD
L-Arginine—ARG2—hematopoietic system—sarcoma	0.0022	0.0173	CbGeAlD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—MITF—sarcoma	0.00216	0.0164	CbGpPWpGaD
L-Arginine—ASL—testis—sarcoma	0.00215	0.0169	CbGeAlD
L-Arginine—Platelet count decreased—Mitoxantrone—sarcoma	0.00205	0.0328	CcSEcCtD
L-Arginine—ASL—liver—sarcoma	0.00203	0.016	CbGeAlD
L-Arginine—SLC7A1—uterus—sarcoma	0.00194	0.0153	CbGeAlD
L-Arginine—ASS1—myometrium—sarcoma	0.00179	0.0141	CbGeAlD
L-Arginine—Necrosis—Dactinomycin—sarcoma	0.00178	0.0286	CcSEcCtD
L-Arginine—NOS3—Angiogenesis—FLT1—sarcoma	0.00176	0.0133	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—PLCG1—sarcoma	0.00173	0.0131	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—EZR—sarcoma	0.00172	0.013	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TEK—sarcoma	0.0017	0.0129	CbGpPWpGaD
L-Arginine—AZIN2—lymph node—sarcoma	0.00167	0.0132	CbGeAlD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—TEK—sarcoma	0.00166	0.0126	CbGpPWpGaD
L-Arginine—ARG2—uterus—sarcoma	0.00166	0.0131	CbGeAlD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.00166	0.0126	CbGpPWpGaD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.00163	0.0124	CbGpPWpGaD
L-Arginine—Skin necrosis—Epirubicin—sarcoma	0.00163	0.026	CcSEcCtD
L-Arginine—ASS1—seminal vesicle—sarcoma	0.00162	0.0128	CbGeAlD
L-Arginine—Extravasation—Thiotepa—sarcoma	0.00162	0.0259	CcSEcCtD
L-Arginine—SLC22A4—mammary gland—sarcoma	0.00161	0.0127	CbGeAlD
L-Arginine—Extravasation—Dactinomycin—sarcoma	0.0016	0.0257	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	0.00156	0.0119	CbGpPWpGaD
L-Arginine—ASL—lymph node—sarcoma	0.00156	0.0123	CbGeAlD
L-Arginine—Necrosis—Mitoxantrone—sarcoma	0.00155	0.0249	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—ANGPT2—sarcoma	0.00155	0.0118	CbGpPWpGaD
L-Arginine—NOS3—hematopoietic system—sarcoma	0.00154	0.0121	CbGeAlD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—sarcoma	0.00152	0.0116	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—FLT1—sarcoma	0.00151	0.0115	CbGpPWpGaD
L-Arginine—Numbness—Vincristine—sarcoma	0.00151	0.0242	CcSEcCtD
L-Arginine—Skin necrosis—Doxorubicin—sarcoma	0.0015	0.0241	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—PLCG1—sarcoma	0.00148	0.0113	CbGpPWpGaD
L-Arginine—NOS3—connective tissue—sarcoma	0.00148	0.0117	CbGeAlD
L-Arginine—NOS3—SHP2 signaling—TEK—sarcoma	0.00148	0.0112	CbGpPWpGaD
L-Arginine—ARG2—tendon—sarcoma	0.00145	0.0115	CbGeAlD
L-Arginine—Sensory loss—Vincristine—sarcoma	0.00144	0.0231	CcSEcCtD
L-Arginine—Extravasation—Vincristine—sarcoma	0.00143	0.023	CcSEcCtD
L-Arginine—SLC7A1—testis—sarcoma	0.00141	0.0111	CbGeAlD
L-Arginine—Extravasation—Mitoxantrone—sarcoma	0.0014	0.0224	CcSEcCtD
L-Arginine—ASS1—smooth muscle tissue—sarcoma	0.00136	0.0107	CbGeAlD
L-Arginine—NOS3—smooth muscle tissue—sarcoma	0.00135	0.0107	CbGeAlD
L-Arginine—Skin exfoliation—Thiotepa—sarcoma	0.00135	0.0216	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.00135	0.0102	CbGpPWpGaD
L-Arginine—ASS1—skin of body—sarcoma	0.00134	0.0106	CbGeAlD
L-Arginine—NOS3—AGE/RAGE pathway—EZR—sarcoma	0.00133	0.0101	CbGpPWpGaD
L-Arginine—Necrosis—Etoposide—sarcoma	0.00129	0.0207	CcSEcCtD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.00126	0.00959	CbGpPWpGaD
L-Arginine—Numbness—Etoposide—sarcoma	0.00122	0.0196	CcSEcCtD
L-Arginine—ARG2—testis—sarcoma	0.0012	0.0095	CbGeAlD
L-Arginine—NOS3—Angiogenesis—PDGFRA—sarcoma	0.0012	0.00914	CbGpPWpGaD
L-Arginine—Sensory loss—Etoposide—sarcoma	0.00117	0.0187	CcSEcCtD
L-Arginine—ASS1—cardiac atrium—sarcoma	0.00117	0.00922	CbGeAlD
L-Arginine—ASS1—uterus—sarcoma	0.00116	0.00917	CbGeAlD
L-Arginine—Extravasation—Etoposide—sarcoma	0.00116	0.0186	CcSEcCtD
L-Arginine—SLC22A4—myometrium—sarcoma	0.00114	0.009	CbGeAlD
L-Arginine—SLC16A10—hematopoietic system—sarcoma	0.0011	0.00868	CbGeAlD
L-Arginine—NOS3—lymphoid tissue—sarcoma	0.00108	0.00852	CbGeAlD
L-Arginine—SLC22A5—mammary gland—sarcoma	0.00106	0.00839	CbGeAlD
L-Arginine—Lethargy—Dactinomycin—sarcoma	0.00104	0.0166	CcSEcCtD
L-Arginine—SLC22A4—seminal vesicle—sarcoma	0.00103	0.00813	CbGeAlD
L-Arginine—SLC7A1—lymph node—sarcoma	0.00102	0.00805	CbGeAlD
L-Arginine—ASS1—tendon—sarcoma	0.00102	0.00804	CbGeAlD
L-Arginine—NOS3—tendon—sarcoma	0.00102	0.00801	CbGeAlD
L-Arginine—NOS3—Angiogenesis—KDR—sarcoma	0.00101	0.00769	CbGpPWpGaD
L-Arginine—Swelling—Mitoxantrone—sarcoma	0.001	0.0161	CcSEcCtD
L-Arginine—Skin exfoliation—Etoposide—sarcoma	0.000967	0.0155	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000951	0.00722	CbGpPWpGaD
L-Arginine—ARG2—lymph node—sarcoma	0.000873	0.00688	CbGeAlD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.000846	0.00642	CbGpPWpGaD
L-Arginine—ASS1—testis—sarcoma	0.000844	0.00666	CbGeAlD
L-Arginine—NOS3—testis—sarcoma	0.000841	0.00663	CbGeAlD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.000839	0.00637	CbGpPWpGaD
L-Arginine—Swelling—Etoposide—sarcoma	0.000834	0.0134	CcSEcCtD
L-Arginine—ASS1—liver—sarcoma	0.000798	0.00629	CbGeAlD
L-Arginine—NOS3—liver—sarcoma	0.000795	0.00627	CbGeAlD
L-Arginine—SLC16A10—lymphoid tissue—sarcoma	0.000775	0.00611	CbGeAlD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—FLT1—sarcoma	0.000763	0.0058	CbGpPWpGaD
L-Arginine—SLC22A5—myometrium—sarcoma	0.000755	0.00595	CbGeAlD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—CALD1—sarcoma	0.000755	0.00573	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—PDGFRA—sarcoma	0.000755	0.00573	CbGpPWpGaD
L-Arginine—Haematuria—Thiotepa—sarcoma	0.000752	0.0121	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—PLCG1—sarcoma	0.00075	0.0057	CbGpPWpGaD
L-Arginine—SLC16A10—tendon—sarcoma	0.000728	0.00574	CbGeAlD
L-Arginine—Necrosis—Epirubicin—sarcoma	0.000724	0.0116	CcSEcCtD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—SRC—sarcoma	0.000714	0.00542	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—FOXO1—sarcoma	0.000702	0.00533	CbGpPWpGaD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—VEGFA—sarcoma	0.000696	0.00528	CbGpPWpGaD
L-Arginine—SLC7A3—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	0.000695	0.00528	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—FOXO1—sarcoma	0.000694	0.00527	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—PLCG1—sarcoma	0.000694	0.00527	CbGpPWpGaD
L-Arginine—SLC22A5—seminal vesicle—sarcoma	0.000682	0.00538	CbGeAlD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—FOXO1—sarcoma	0.000681	0.00517	CbGpPWpGaD
L-Arginine—Sweating—Vincristine—sarcoma	0.000671	0.0107	CcSEcCtD
L-Arginine—Necrosis—Doxorubicin—sarcoma	0.00067	0.0107	CcSEcCtD
L-Arginine—Sweating—Mitoxantrone—sarcoma	0.000653	0.0105	CcSEcCtD
L-Arginine—Flushing—Dactinomycin—sarcoma	0.000653	0.0105	CcSEcCtD
L-Arginine—Extravasation—Epirubicin—sarcoma	0.000651	0.0104	CcSEcCtD
L-Arginine—Haematuria—Mitoxantrone—sarcoma	0.00065	0.0104	CcSEcCtD
L-Arginine—SLC22A4—tendon—sarcoma	0.000649	0.00511	CbGeAlD
L-Arginine—NOS3—SHP2 signaling—IGF1R—sarcoma	0.000635	0.00482	CbGpPWpGaD
L-Arginine—SLC22A4—bone marrow—sarcoma	0.000628	0.00495	CbGeAlD
L-Arginine—NOS3—Signaling by VEGF—VEGFC—sarcoma	0.000627	0.00476	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Vincristine—sarcoma	0.000625	0.01	CcSEcCtD
L-Arginine—ASS1—lymph node—sarcoma	0.000612	0.00482	CbGeAlD
L-Arginine—NOS3—lymph node—sarcoma	0.00061	0.00481	CbGeAlD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.000609	0.00462	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—PDGFRB—sarcoma	0.000604	0.00458	CbGpPWpGaD
L-Arginine—SLC16A10—testis—sarcoma	0.000603	0.00475	CbGeAlD
L-Arginine—Extravasation—Doxorubicin—sarcoma	0.000602	0.00965	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—IL2—sarcoma	0.000598	0.00454	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—PLCG1—sarcoma	0.000589	0.00447	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—sarcoma	0.000585	0.00444	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—SRC—sarcoma	0.000573	0.00435	CbGpPWpGaD
L-Arginine—SLC16A10—liver—sarcoma	0.00057	0.00449	CbGeAlD
L-Arginine—Injection site reaction—Epirubicin—sarcoma	0.000565	0.00904	CcSEcCtD
L-Arginine—SLC22A5—skin of body—sarcoma	0.000564	0.00445	CbGeAlD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—CTNNB1—sarcoma	0.000561	0.00426	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—VEGFA—sarcoma	0.000558	0.00424	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CREB1—sarcoma	0.000557	0.00423	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—FOXO1—sarcoma	0.000545	0.00414	CbGpPWpGaD
L-Arginine—Skin exfoliation—Epirubicin—sarcoma	0.000542	0.00869	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.000539	0.00409	CbGpPWpGaD
L-Arginine—Injection site reaction—Doxorubicin—sarcoma	0.000522	0.00837	CcSEcCtD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—PLCG1—sarcoma	0.000522	0.00396	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—MMP2—sarcoma	0.000519	0.00394	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000509	0.00387	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Etoposide—sarcoma	0.000506	0.00811	CcSEcCtD
L-Arginine—Skin exfoliation—Doxorubicin—sarcoma	0.000502	0.00804	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—FLT1—sarcoma	0.000501	0.00381	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—KDR—sarcoma	0.0005	0.0038	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—PLCG1—sarcoma	0.000493	0.00374	CbGpPWpGaD
L-Arginine—SLC22A5—cardiac atrium—sarcoma	0.000492	0.00388	CbGeAlD
L-Arginine—NOS3—Leptin signaling pathway—FOXO1—sarcoma	0.000492	0.00374	CbGpPWpGaD
L-Arginine—Tachycardia—Thiotepa—sarcoma	0.000491	0.00787	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—VEGFA—sarcoma	0.00048	0.00364	CbGpPWpGaD
L-Arginine—Anorexia—Thiotepa—sarcoma	0.00048	0.00768	CcSEcCtD
L-Arginine—Anorexia—Dactinomycin—sarcoma	0.000476	0.00763	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—MMP2—sarcoma	0.000474	0.0036	CbGpPWpGaD
L-Arginine—Flushing—Etoposide—sarcoma	0.000472	0.00756	CcSEcCtD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—sarcoma	0.00046	0.00349	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—sarcoma	0.000453	0.00344	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUN—sarcoma	0.000452	0.00343	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Vincristine—sarcoma	0.000446	0.00715	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—KDR—sarcoma	0.00044	0.00334	CbGpPWpGaD
L-Arginine—Decreased appetite—Thiotepa—sarcoma	0.000437	0.00701	CcSEcCtD
L-Arginine—SLC16A10—lymph node—sarcoma	0.000437	0.00345	CbGeAlD
L-Arginine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000435	0.00696	CcSEcCtD
L-Arginine—Decreased appetite—Dactinomycin—sarcoma	0.000434	0.00695	CcSEcCtD
L-Arginine—Hyperhidrosis—Vincristine—sarcoma	0.000431	0.00691	CcSEcCtD
L-Arginine—SLC22A5—tendon—sarcoma	0.000429	0.00338	CbGeAlD
L-Arginine—Anorexia—Vincristine—sarcoma	0.000425	0.00681	CcSEcCtD
L-Arginine—Tachycardia—Mitoxantrone—sarcoma	0.000424	0.00679	CcSEcCtD
L-Arginine—Lethargy—Epirubicin—sarcoma	0.000421	0.00674	CcSEcCtD
L-Arginine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00042	0.00673	CcSEcCtD
L-Arginine—Anorexia—Mitoxantrone—sarcoma	0.000414	0.00664	CcSEcCtD
L-Arginine—NOS2—IL12-mediated signaling events—IL2—sarcoma	0.000406	0.00309	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000402	0.00305	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CCND1—sarcoma	0.000402	0.00305	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—JUN—sarcoma	0.000401	0.00304	CbGpPWpGaD
L-Arginine—Lethargy—Doxorubicin—sarcoma	0.000389	0.00624	CcSEcCtD
L-Arginine—SLC22A4—lymph node—sarcoma	0.000389	0.00307	CbGeAlD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—PLCG1—sarcoma	0.000388	0.00295	CbGpPWpGaD
L-Arginine—Decreased appetite—Vincristine—sarcoma	0.000388	0.00621	CcSEcCtD
L-Arginine—Decreased appetite—Mitoxantrone—sarcoma	0.000378	0.00605	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—PLCG1—sarcoma	0.000375	0.00285	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000373	0.00284	CbGpPWpGaD
L-Arginine—Hypersensitivity—Thiotepa—sarcoma	0.000371	0.00594	CcSEcCtD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—ATF1—sarcoma	0.000369	0.0028	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—MMP2—sarcoma	0.000368	0.0028	CbGpPWpGaD
L-Arginine—Hypersensitivity—Dactinomycin—sarcoma	0.000368	0.00589	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000366	0.00278	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—JUN—sarcoma	0.000366	0.00278	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Etoposide—sarcoma	0.000362	0.00579	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.000359	0.00273	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—sarcoma	0.000359	0.00273	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—CREB1—sarcoma	0.000357	0.00271	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ATF1—sarcoma	0.000356	0.0027	CbGpPWpGaD
L-Arginine—SLC22A5—testis—sarcoma	0.000355	0.0028	CbGeAlD
L-Arginine—Tachycardia—Etoposide—sarcoma	0.000353	0.00565	CcSEcCtD
L-Arginine—Hyperhidrosis—Etoposide—sarcoma	0.000349	0.0056	CcSEcCtD
L-Arginine—Anorexia—Etoposide—sarcoma	0.000345	0.00552	CcSEcCtD
L-Arginine—NOS2—Hemostasis—TEK—sarcoma	0.000336	0.00255	CbGpPWpGaD
L-Arginine—SLC22A5—liver—sarcoma	0.000336	0.00265	CbGeAlD
L-Arginine—Hypersensitivity—Vincristine—sarcoma	0.000329	0.00527	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—SRC—sarcoma	0.000329	0.0025	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—SRC—sarcoma	0.000325	0.00247	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IL2—sarcoma	0.000324	0.00246	CbGpPWpGaD
L-Arginine—Hypersensitivity—Mitoxantrone—sarcoma	0.00032	0.00513	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.00032	0.00243	CbGpPWpGaD
L-Arginine—Vomiting—Thiotepa—sarcoma	0.00032	0.00513	CcSEcCtD
L-Arginine—Vomiting—Dactinomycin—sarcoma	0.000318	0.00509	CcSEcCtD
L-Arginine—Rash—Thiotepa—sarcoma	0.000317	0.00508	CcSEcCtD
L-Arginine—Dermatitis—Thiotepa—sarcoma	0.000317	0.00508	CcSEcCtD
L-Arginine—Headache—Thiotepa—sarcoma	0.000315	0.00505	CcSEcCtD
L-Arginine—Rash—Dactinomycin—sarcoma	0.000315	0.00504	CcSEcCtD
L-Arginine—AZIN2—Metabolism—ENO2—sarcoma	0.000315	0.00239	CbGpPWpGaD
L-Arginine—Decreased appetite—Etoposide—sarcoma	0.000314	0.00503	CcSEcCtD
L-Arginine—AZIN2—Metabolism—HBA1—sarcoma	0.000313	0.00238	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—sarcoma	0.000312	0.00237	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000309	0.00235	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—ANGPT2—sarcoma	0.000308	0.00234	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KDR—sarcoma	0.000306	0.00233	CbGpPWpGaD
L-Arginine—Sweating—Epirubicin—sarcoma	0.000305	0.00488	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—CREB1—sarcoma	0.000303	0.0023	CbGpPWpGaD
L-Arginine—Haematuria—Epirubicin—sarcoma	0.000303	0.00485	CcSEcCtD
L-Arginine—Nausea—Thiotepa—sarcoma	0.000299	0.00479	CcSEcCtD
L-Arginine—Nausea—Dactinomycin—sarcoma	0.000297	0.00475	CcSEcCtD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—SRC—sarcoma	0.000291	0.00221	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MYC—sarcoma	0.000291	0.00221	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—KDR—sarcoma	0.000289	0.0022	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—EGFR—sarcoma	0.000288	0.00219	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ENO2—sarcoma	0.000288	0.00219	CbGpPWpGaD
L-Arginine—ASL—Metabolism—HBA1—sarcoma	0.000286	0.00217	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—sarcoma	0.000285	0.00216	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—JUN—sarcoma	0.000284	0.00216	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Epirubicin—sarcoma	0.000284	0.00455	CcSEcCtD
L-Arginine—Vomiting—Vincristine—sarcoma	0.000284	0.00454	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—sarcoma	0.000282	0.00451	CcSEcCtD
L-Arginine—Rash—Vincristine—sarcoma	0.000281	0.00451	CcSEcCtD
L-Arginine—Dermatitis—Vincristine—sarcoma	0.000281	0.0045	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—sarcoma	0.00028	0.00449	CcSEcCtD
L-Arginine—Headache—Vincristine—sarcoma	0.00028	0.00448	CcSEcCtD
L-Arginine—Vomiting—Mitoxantrone—sarcoma	0.000276	0.00443	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—sarcoma	0.000276	0.00209	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—VEGFA—sarcoma	0.000276	0.00209	CbGpPWpGaD
L-Arginine—Rash—Mitoxantrone—sarcoma	0.000274	0.00439	CcSEcCtD
L-Arginine—Dermatitis—Mitoxantrone—sarcoma	0.000274	0.00439	CcSEcCtD
L-Arginine—Headache—Mitoxantrone—sarcoma	0.000272	0.00436	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—NRAS—sarcoma	0.000272	0.00207	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—sarcoma	0.000269	0.00204	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PLCG1—sarcoma	0.000267	0.00203	CbGpPWpGaD
L-Arginine—Hypersensitivity—Etoposide—sarcoma	0.000266	0.00427	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—FOXO1—sarcoma	0.000266	0.00202	CbGpPWpGaD
L-Arginine—Nausea—Vincristine—sarcoma	0.000265	0.00425	CcSEcCtD
L-Arginine—Flushing—Epirubicin—sarcoma	0.000265	0.00424	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000263	0.002	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Doxorubicin—sarcoma	0.000263	0.00421	CcSEcCtD
L-Arginine—NOS3—Hemostasis—TEK—sarcoma	0.000261	0.00198	CbGpPWpGaD
L-Arginine—Nausea—Mitoxantrone—sarcoma	0.000258	0.00414	CcSEcCtD
L-Arginine—SLC22A5—lymph node—sarcoma	0.000258	0.00203	CbGeAlD
L-Arginine—NOS3—Leptin signaling pathway—CCND1—sarcoma	0.000257	0.00195	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—SRC—sarcoma	0.000255	0.00194	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—EGFR—sarcoma	0.000255	0.00194	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—SRC—sarcoma	0.000249	0.00189	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—EGFR—sarcoma	0.000248	0.00188	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFC—sarcoma	0.000247	0.00187	CbGpPWpGaD
L-Arginine—Flushing—Doxorubicin—sarcoma	0.000245	0.00392	CcSEcCtD
L-Arginine—ASL—Metabolism—PLCG1—sarcoma	0.000244	0.00186	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—sarcoma	0.000243	0.00184	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—sarcoma	0.000239	0.00181	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—ANGPT2—sarcoma	0.000239	0.00181	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ENO2—sarcoma	0.000239	0.00181	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—HBA1—sarcoma	0.000237	0.0018	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL2—sarcoma	0.000237	0.0018	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—KRAS—sarcoma	0.000234	0.00178	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CCND1—sarcoma	0.000231	0.00175	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—SRC—sarcoma	0.00023	0.00175	CbGpPWpGaD
L-Arginine—Vomiting—Etoposide—sarcoma	0.00023	0.00368	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—sarcoma	0.000229	0.00174	CbGpPWpGaD
L-Arginine—Rash—Etoposide—sarcoma	0.000228	0.00365	CcSEcCtD
L-Arginine—Dermatitis—Etoposide—sarcoma	0.000228	0.00365	CcSEcCtD
L-Arginine—Headache—Etoposide—sarcoma	0.000226	0.00363	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—IL2—sarcoma	0.000224	0.0017	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—EGFR—sarcoma	0.000224	0.0017	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—CTNNB1—sarcoma	0.000216	0.00164	CbGpPWpGaD
L-Arginine—Nausea—Etoposide—sarcoma	0.000215	0.00344	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—CREB1—sarcoma	0.000209	0.00159	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Epirubicin—sarcoma	0.000203	0.00325	CcSEcCtD
L-Arginine—ARG2—Metabolism—PLCG1—sarcoma	0.000202	0.00154	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—CREB1—sarcoma	0.0002	0.00152	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—HRAS—sarcoma	0.000199	0.00151	CbGpPWpGaD
L-Arginine—Tachycardia—Epirubicin—sarcoma	0.000198	0.00317	CcSEcCtD
L-Arginine—Hyperhidrosis—Epirubicin—sarcoma	0.000196	0.00314	CcSEcCtD
L-Arginine—NOS2—Hemostasis—PLCG1—sarcoma	0.000194	0.00147	CbGpPWpGaD
L-Arginine—Anorexia—Epirubicin—sarcoma	0.000193	0.00309	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—CREB1—sarcoma	0.000193	0.00146	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—CTNNB1—sarcoma	0.000192	0.00146	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFC—sarcoma	0.000192	0.00146	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Doxorubicin—sarcoma	0.000188	0.003	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—MYC—sarcoma	0.000185	0.0014	CbGpPWpGaD
L-Arginine—Tachycardia—Doxorubicin—sarcoma	0.000183	0.00293	CcSEcCtD
L-Arginine—Hyperhidrosis—Doxorubicin—sarcoma	0.000181	0.0029	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—CTNNB1—sarcoma	0.000181	0.00137	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—EGFR—sarcoma	0.000181	0.00137	CbGpPWpGaD
L-Arginine—Anorexia—Doxorubicin—sarcoma	0.000179	0.00286	CcSEcCtD
L-Arginine—Decreased appetite—Epirubicin—sarcoma	0.000176	0.00282	CcSEcCtD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—SRC—sarcoma	0.000173	0.00132	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—sarcoma	0.000169	0.00128	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—NRAS—sarcoma	0.000167	0.00127	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ENO2—sarcoma	0.000165	0.00126	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—HBA1—sarcoma	0.000164	0.00125	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—SRC—sarcoma	0.000164	0.00124	CbGpPWpGaD
L-Arginine—Decreased appetite—Doxorubicin—sarcoma	0.000163	0.00261	CcSEcCtD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—sarcoma	0.000162	0.00123	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—VEGFA—sarcoma	0.000159	0.00121	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—NRAS—sarcoma	0.000157	0.0012	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—sarcoma	0.000152	0.00115	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PLCG1—sarcoma	0.000151	0.00114	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—JUN—sarcoma	0.00015	0.00114	CbGpPWpGaD
L-Arginine—Hypersensitivity—Epirubicin—sarcoma	0.000149	0.00239	CcSEcCtD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—JUN—sarcoma	0.000144	0.00109	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KRAS—sarcoma	0.000144	0.00109	CbGpPWpGaD
L-Arginine—NOS2—Disease—TLE1—sarcoma	0.000142	0.00108	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PLCG1—sarcoma	0.00014	0.00107	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—JUN—sarcoma	0.000139	0.00105	CbGpPWpGaD
L-Arginine—Hypersensitivity—Doxorubicin—sarcoma	0.000138	0.00221	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—KRAS—sarcoma	0.000135	0.00103	CbGpPWpGaD
L-Arginine—Vomiting—Epirubicin—sarcoma	0.000129	0.00206	CcSEcCtD
L-Arginine—NOS2—Disease—NPM1—sarcoma	0.000128	0.00097	CbGpPWpGaD
L-Arginine—Rash—Epirubicin—sarcoma	0.000128	0.00205	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—sarcoma	0.000128	0.00204	CcSEcCtD
L-Arginine—Headache—Epirubicin—sarcoma	0.000127	0.00203	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—SRC—sarcoma	0.000124	0.000945	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—sarcoma	0.000122	0.000926	CbGpPWpGaD
L-Arginine—Nausea—Epirubicin—sarcoma	0.00012	0.00193	CcSEcCtD
L-Arginine—Vomiting—Doxorubicin—sarcoma	0.000119	0.00191	CcSEcCtD
L-Arginine—Rash—Doxorubicin—sarcoma	0.000118	0.00189	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—sarcoma	0.000118	0.00189	CcSEcCtD
L-Arginine—Headache—Doxorubicin—sarcoma	0.000117	0.00188	CcSEcCtD
L-Arginine—NOS3—Signaling by VEGF—HRAS—sarcoma	0.000115	0.000874	CbGpPWpGaD
L-Arginine—Nausea—Doxorubicin—sarcoma	0.000111	0.00178	CcSEcCtD
L-Arginine—NOS2—Disease—ENO2—sarcoma	0.000111	0.000841	CbGpPWpGaD
L-Arginine—NOS3—Disease—TLE1—sarcoma	0.00011	0.000835	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—EGFR—sarcoma	0.000109	0.000828	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—KRAS—sarcoma	0.000103	0.000782	CbGpPWpGaD
L-Arginine—NOS3—Disease—NPM1—sarcoma	9.92e-05	0.000753	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—sarcoma	9.92e-05	0.000753	CbGpPWpGaD
L-Arginine—NOS2—Disease—PLCG1—sarcoma	9.39e-05	0.000713	CbGpPWpGaD
L-Arginine—NOS2—Disease—CXCR4—sarcoma	9.03e-05	0.000685	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—sarcoma	8.76e-05	0.000665	CbGpPWpGaD
L-Arginine—NOS3—Disease—ENO2—sarcoma	8.6e-05	0.000653	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TLE1—sarcoma	7.7e-05	0.000585	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IL2—sarcoma	7.38e-05	0.000561	CbGpPWpGaD
L-Arginine—NOS3—Disease—PLCG1—sarcoma	7.29e-05	0.000554	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ENO2—sarcoma	7.2e-05	0.000547	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HBA1—sarcoma	7.15e-05	0.000543	CbGpPWpGaD
L-Arginine—NOS3—Disease—CXCR4—sarcoma	7.01e-05	0.000532	CbGpPWpGaD
L-Arginine—NOS2—Disease—FOXO1—sarcoma	6.67e-05	0.000506	CbGpPWpGaD
L-Arginine—NOS2—Disease—PDGFRB—sarcoma	6.65e-05	0.000505	CbGpPWpGaD
L-Arginine—NOS2—Disease—PDGFRA—sarcoma	6.55e-05	0.000497	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFC—sarcoma	6.5e-05	0.000494	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SRC—sarcoma	6.44e-05	0.000489	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—sarcoma	6.27e-05	0.000476	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—sarcoma	6.2e-05	0.000471	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PLCG1—sarcoma	6.11e-05	0.000464	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—sarcoma	5.73e-05	0.000435	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—sarcoma	5.33e-05	0.000405	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FLT1—sarcoma	5.2e-05	0.000395	CbGpPWpGaD
L-Arginine—NOS3—Disease—FOXO1—sarcoma	5.18e-05	0.000393	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFRB—sarcoma	5.17e-05	0.000392	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PLCG1—sarcoma	5.11e-05	0.000388	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFRA—sarcoma	5.09e-05	0.000386	CbGpPWpGaD
L-Arginine—NOS2—Disease—KIT—sarcoma	5.08e-05	0.000386	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SRC—sarcoma	5e-05	0.00038	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCR4—sarcoma	4.91e-05	0.000373	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—sarcoma	4.87e-05	0.00037	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ATF1—sarcoma	4.85e-05	0.000368	CbGpPWpGaD
L-Arginine—NOS2—Disease—CREB1—sarcoma	4.83e-05	0.000367	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—sarcoma	4.81e-05	0.000365	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—sarcoma	4.74e-05	0.00036	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—sarcoma	4.53e-05	0.000344	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—sarcoma	4.14e-05	0.000314	CbGpPWpGaD
L-Arginine—NOS2—Disease—MDM2—sarcoma	4e-05	0.000304	CbGpPWpGaD
L-Arginine—NOS3—Disease—KIT—sarcoma	3.94e-05	0.000299	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1R—sarcoma	3.81e-05	0.000289	CbGpPWpGaD
L-Arginine—NOS3—Disease—CREB1—sarcoma	3.75e-05	0.000285	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—sarcoma	3.68e-05	0.000279	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FOXO1—sarcoma	3.62e-05	0.000275	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFRB—sarcoma	3.62e-05	0.000275	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFRA—sarcoma	3.56e-05	0.00027	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—sarcoma	3.52e-05	0.000267	CbGpPWpGaD
L-Arginine—NOS2—Disease—CTNNB1—sarcoma	3.45e-05	0.000262	CbGpPWpGaD
L-Arginine—NOS2—Disease—SRC—sarcoma	3.12e-05	0.000237	CbGpPWpGaD
L-Arginine—NOS3—Disease—MDM2—sarcoma	3.11e-05	0.000236	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—sarcoma	3e-05	0.000228	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KDR—sarcoma	3e-05	0.000228	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—sarcoma	2.79e-05	0.000212	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KIT—sarcoma	2.76e-05	0.00021	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—sarcoma	2.73e-05	0.000208	CbGpPWpGaD
L-Arginine—NOS3—Disease—CTNNB1—sarcoma	2.68e-05	0.000203	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CREB1—sarcoma	2.63e-05	0.0002	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—sarcoma	2.58e-05	0.000196	CbGpPWpGaD
L-Arginine—NOS3—Disease—SRC—sarcoma	2.42e-05	0.000184	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—sarcoma	2.33e-05	0.000177	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—sarcoma	2.19e-05	0.000167	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MDM2—sarcoma	2.17e-05	0.000165	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—sarcoma	2.17e-05	0.000165	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—sarcoma	2.12e-05	0.000161	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—sarcoma	2e-05	0.000152	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—sarcoma	1.94e-05	0.000148	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—sarcoma	1.89e-05	0.000144	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JUN—sarcoma	1.89e-05	0.000144	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNB1—sarcoma	1.88e-05	0.000142	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—sarcoma	1.7e-05	0.000129	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SRC—sarcoma	1.7e-05	0.000129	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—sarcoma	1.65e-05	0.000125	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—sarcoma	1.63e-05	0.000124	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—sarcoma	1.52e-05	0.000115	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—sarcoma	1.49e-05	0.000113	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—sarcoma	1.4e-05	0.000107	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—sarcoma	1.25e-05	9.48e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—sarcoma	1.19e-05	9.06e-05	CbGpPWpGaD
